FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screening Test for Antibodies to Hepatitis C Virus; Guidance for Industry” was released on October 2, 2019 and recommends that CTS modify our current HCV reflex testing algorithm to support these best practices. The new algorithm will take effect on April 20, 2020.
Check out the Communication page for the complete details by clicking the link: Communications
At CTS, we understand the impact converting to the Ortho viral marker platform has on your operation...
As a service to our partners, CTS provides a copy of all licenses and accreditations on our website....
A new Learning Center website will launch on Monday, March 30, 2020. While the link to the new Learn...
On April 29, 2019, CTS will begin performing Donor-Screen HLA® Class I and II testing on the Str...
As previously mentioned in Zika communications distributed on September 21 and October 12, 2018; ord...
The new online Learning Center with new content can still be found under the “Training” folder on ...